Ovid Therapeutics Inc. revenue for the last year amounted to 391.69 k USD, the most of which — 391.69 k USD — came from its highest performing source at the moment, Novel Therapeutics, the year earlier bringing 1.50 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Ovid Therapeutics Inc. 391.69 k USD, and the year before that — 1.50 M USD.